Scion Life Sciences
Scion Life Sciences is a VC fund. It joined 1 round tracked by OSH in the last 90 days.
What they look for
Not published yet. OSH fills this in from Scion Life Sciences's own site, or from its deals once OSH tracks them.
Activity
Deals, 90 days
1
Deals, 12 months
1
Led, 12 months
1
Median disclosed round
$173M
Frequent co-investors:Venbio PartnersOrbiMedRTW InvestmentsSurveyor CapitalOpaleye
Portfolio from OSH Rounds
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $173M | Series B | Scion Life Sciences, Venbio Partners, OrbiMed | RTW Investments +7 | — | 1 |
Nov 17 · Series B
Marrow Therapeutics$173MLed by Scion Life Sciences, Venbio Partners, OrbiMed · with RTW Investments, +7
Questions and answers
How active is Scion Life Sciences?
In OSH Rounds, Scion Life Sciences joined 1 round in the last 90 days and 1 in the last 12 months, leading 1.
Sources
- 1.Sickle Cell Drug: Marrow Raises $173 Million Without Releasing Anemia or Selectivity Data — techtimes.com, Nov 17, 2026